Pera Antonio R's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Aug 15, 2023
- Accession no.
- 0001689325-23-000002
- Filed
- Aug 15, 2023
- Trade date
- Aug 14, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $181.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pera Antonio RCIK 0001689325 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Common Stock | SSaleDisposed | −3,000 | $60.37F1 | −$181,110 | 33,627 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive.
Referenced by the price of 1 transaction in Table I.